Get Enquiry

Flu Virus

Application Details :

The flu virus, short for influenza virus, is a highly contagious respiratory infection that affects humans and other animals. It belongs to the Orthomyxoviridae family and is divided into three types: A, B, and C. Influenza A viruses are the most dangerous and have the potential to trigger pandemics. The flu virus spreads mostly by respiratory droplets produced by an infected person speaking, coughing, or sneezing. It can also be contracted by touching a virus-contaminated surface or object and then touching one's face, particularly the mouth, nose, or eyes. The flu has an incubation period of one to four days, during which an infected person may inadvertently spread the virus. Flu symptoms can range from mild to severe, including fever, chills, cough, sore throat, runny or stuffy nose, muscular or body pains, headaches, exhaustion, and, in rare cases, gastrointestinal problems such as nausea and vomiting. In severe situations, the flu can cause pneumonia, exacerbation of pre-existing medical issues, and even mortality, especially in susceptible groups including the elderly, small children, and those with compromised immune systems. Vaccination is an important preventive measure for the flu. Annual flu vaccines are designed to protect against the most common types of the virus. Vaccination not only reduces the intensity of the illness, but it also prevents it from spreading throughout communities. Antiviral drugs, such as oseltamivir (Tamiflu), may be used to treat the flu, particularly if given early in the disease. However, these drugs are not a replacement for vaccinations. Efforts to control the spread of the flu also include adopting excellent respiratory hygiene, such as covering the mouth and nose while coughing or sneezing, frequent handwashing, and remaining at home when unwell to prevent virus transmission to others. Monitoring and comprehending the flu virus's genetic variants is critical for the development of effective vaccines and antivirals. The virus's continual development through genetic reassortment and mutation presents hurdles in sustaining long-term immunity, making ongoing research and surveillance critical in the fight against influenza.